Literature DB >> 16193596

Three young adult patients with Pelizaeus-Merzbacher disease who showed only waves I and II in auditory brainstem responses but had good auditory perception.

Kimitaka Kaga1, Fumi Tamai, Mariko Kodama, Kazuo Kodama.   

Abstract

Three young adult males with Pelizaeus-Merzbacher disease have been followed up since childhood. This disease is thought to be a dysmyelinating disorder of the brain during the prenatal period caused by gene mutations. The patients manifested horizontal nystagmus and severe rigidity of the extremities. Although the patients showed only waves I and II in auditory brainstem responses, they had relatively good hearing ability at approximately equal to dB. They could not speak words at all but could hear well and enjoy listening to conversation and music. One of them had a normal hearing threshold in pure-tone audiometry and a normal speech discrimination rate in speech audiometry. This can be explained by a nerve conduction blockade through dysmyelinated axons or the desynchronization of neurons and nerves responsible for the waves following waves I and II. At present, all three patients are living with their families. We report their present hearing, speech and language abilities.

Entities:  

Mesh:

Year:  2005        PMID: 16193596     DOI: 10.1080/00016480510038581

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Murine malaria is associated with significant hearing impairment.

Authors:  Joachim Schmutzhard; Christian H Kositz; Peter Lackner; Anelia Dietmann; Marlene Fischer; Rudolf Glueckert; Markus Reindl; Kurt Stephan; Herbert Riechelmann; Annelies Schrott-Fischer; Erich Schmutzhard
Journal:  Malar J       Date:  2010-06-11       Impact factor: 2.979

2.  Auditory function in Pelizaeus-Merzbacher disease.

Authors:  Thierry Morlet; Kyoko Nagao; S Charles Bean; Sara E Mora; Sarah E Hopkins; Grace M Hobson
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.